OFFICIAL LEGAL TITLE
Access to Future Cures Act
FREQUENTLY ASKED QUESTIONS
What is the official ID of this bill?
The official print number for this legislation is 118_HR_1170.
Which chamber initiated this legislation?
This legislation was initiated in the House of Representatives.
When did the legislative process begin?
The process officially started on 2023-02-24.
What are the main provisions?
Key points include:
- Expenses for storing blood and blood-derived biomaterials will be considered medical expenses.
- Potential for tax deductions on these costs, leading to savings.
- Changes apply to expenses paid or incurred after the act's enactment date.
What is the specific legal status?
The current status is Expired.
Where can I read the full text of this legislation?
The full official text is available at:
View full text
Who is the primary sponsor?
The primary sponsor is Rep. Arrington, Jodey C. [R-TX-19].
What is the latest detailed status?
The latest detailed status is: Referred to the Subcommittee on Health.
Is this summary verified?
Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-24.